It is possible that similar to Akt (but not NHE1) expression, the effects of TME on proliferation and survival are at least partially compensated in vivo, e.g. by VEGF and survival factors released from the cancer cells and other stromal cells [8]. This evidence concerns the gene SLC9A1 and cancer.